Telix Pharmaceuticals Ltd
(ASX:TLX)
A$
23.84
0 (0%)
Market Cap: 7.98 Bil
Enterprise Value: 7.98 Bil
PE Ratio: 160.00
PB Ratio: 19.72
GF Score: 69/100 Telix Pharmaceuticals Ltd ASCO-GU ZIRCON Phase III Results Presentation Transcript
Feb 20, 2023 / 09:30PM GMT
Release Date Price:
A$6.14
Kyahn Williamson
Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR
Presentation
Feb 20, 2023 / 09:30PM GMT
=====================
Corporate Participants
=====================
* Colin Hayward
Telix Pharmaceuticals Limited - Group Chief Medical Officer
* Kyahn Williamson
Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR
=====================
Conference Call Participants
=====================
* Dennis Hulme
Taylor Collison Limited, Research Division - Biotech & Healthcare Analyst
* Shane A. Storey
Wilsons Advisory and Stockbroking Limited, Research Division - Senior Analyst
* Steven David Wheen
Jarden Australia Pty Limited, Research Division - Head of Healthcare, Equity Research
* Brian M. Shuch
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot